PDE7A (catalytic domain) (human), (recombinant) from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
PDE7A (catalytic domain) (human), (recombinant)

Get Pricing

Description

PDE7A is expressed in immune and pro-inflammatory cells. It is being investigated as an alternate target to PDE4 for the inhibition of inflammation that is associated with many inflammatory diseases including asthma, chronic obstructive pulmonary disease, atopic dermatitis, psoriasis, lupus, rheumatoid arthritis and multiple sclerosis